#Pfizer started testing vaccine in pregnant women
Pfizer and BioNTech have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women, the companies said on Thursday. Drugmakers have said they first need to make sure the vaccines are safe and effective more generally. Pregnant women in the United States have already received their first doses, the companies said. The new study will test pregnant women aged 18 and older in the United States, Canada, Argentina, Brazil, Chile, Mozambique, South Africa, the UK and Spain. Women will receive the vaccine during weeks 24-34 of gestation, getting two shots 21 days apart - the same regimen used in the larger clinical trial. |
Pig kidney transplanted into living person for first time (photo)
606621.03.2024, 20:48First person dies from Alaskapox virus
149412.02.2024, 18:06Record-breaking doctors' strike piles pressure on England's health service
288403.01.2024, 19:30China Hospitals overwhelmed with children suffering pneumonia
691723.11.2023, 10:18WHO Concerned by Report of Israeli Evacuation Warning to Gaza Al-Quds Hospital
367529.10.2023, 19:00Pakistan police bust organ trafficking ring that took kidneys from hundreds
338320.10.2023, 23:42